Insulet
PODD
₹22,235
Share price
-2.65%
Change (1 day)
50.09%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Earnings for Insulet (PODD)
Earnings in 2024 (TTM): ₹28.91 Billion
According to Insulet's latest financial reports the company's current earnings are ₹2.07 Billion. , an increase over its 2023 earnings that were of ₹21.63 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Insulet from 2006 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | ₹29.58 B | 36.72% |
| 2023 | ₹21.63 B | 481.9% |
| 2022 | ₹3.71 B | -45.24% |
| 2021 | ₹6.79 B | 43.35% |
| 2020 | ₹4.73 B | 18.51% |
| 2019 | ₹3.99 B | 41.16% |
| 2018 | ₹2.83 B | -711.95% |
| 2017 | -₹0.47 Billion | -56.85% |
| 2016 | -₹1.08 Billion | -79.31% |
| 2015 | -₹5.19 Billion | 63.85% |
| 2014 | -₹3.17 Billion | 31.04% |
| 2013 | -₹2.42 Billion | -21.96% |
| 2012 | -₹3.1 Billion | |
| 2010 | -₹2.96 Billion | -42.38% |
| 2009 | -₹5.13 Billion | -33.56% |
| 2008 | -₹7.71 Billion | 65.93% |
| 2007 | -₹4.65 Billion | 209.75% |
| 2006 | -₹1.5 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | ₹3.49 B | -88.18% | 🇺🇸 USA |
 | -₹8.07 Billion | -127.25% | 🇺🇸 USA |
 | ₹62.81 B | 112.31% | 🇺🇸 USA |
 | ₹1.504 T | 4,986.61% | 🇺🇸 USA |
 | ₹605.09 B | 1,945.20% | 🇺🇸 USA |
 | ₹515.88 B | 1,643.66% | 🇮🇪 Ireland |
 | ₹1.094 T | 3,597.99% | 🇺🇸 USA |